-
How to find a specialist for chronic lymphocytic leukemia (CLL)
18 Jun 2025 16:57 GMT
Chronic lymphocytic leukemia (CLL) is a type of …
-
CAR-T Cell Therapy Market to Surpass $20.4B by 2033, Fueled by Oncology Breakthroughs and R&D Push | DataM Intelligence
20 Jun 2025 12:45 GMT
… -cell Lymphoma (DLBCL)
Multiple Myeloma
Chronic Lymphocytic Leukemia (CLL)
Solid Tumors
Others
By …
-
From Trial to Practice in the Evolving Landscape of Hematologic Malignancies
20 Jun 2025 04:51 GMT
… we looped back to CLL [chronic lymphocytic leukemia], a more chronic type of …
-
Venetoclax Effective in Older Patients With CLL
20 Jun 2025 02:23 GMT
… response rate in octogenarians with chronic lymphocytic leukemia (CLL), but clinicians should expect …
2. SEER cancer stat facts — chronic lymphocytic leukemia (CLL). Surveillance, Epidemiology, and End …
-
Conversations About BTK Inhibitors and CAR T-Cell Therapies Bridge Gaps in Leukemia and Lymphoma: With Alexey Danilov, MD, PhD
19 Jun 2025 19:31 GMT
… inhibitors for the management of chronic lymphocytic leukemia, and the evolution of CD19 …
-
Safety Drives Decision to Move to Zanubrutinib in CLL
19 Jun 2025 15:52 GMT
… , Inc) to treat patients with chronic lymphocytic leukemia (CLL) due to its improved …
-
Phase II TRANSCEND FL Shows Breyanzi Achieves Strong Efficacy, Durable Response in Relapsed Marginal Zone Lymphoma
19 Jun 2025 14:52 GMT
… with R/R chronic lymphocytic leukemia or small lymphocytic lymphoma who … adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic … Adults-with-Relapsed-or-Refractory-Chronic-Lymphocytic-Leukemia-CLL-or-Small-Lymphocytic- …
-
Genetics or Microenvironment: What Drives CLL Progression?
19 Jun 2025 14:21 GMT
MILAN — Is chronic lymphocytic leukemia (CLL) progression primarily driven by …
-
Leukocytosis Market Analysis 2025 – Insights For Long-Term Investment & Planning
19 Jun 2025 06:25 GMT
… include Acute Lymphocytic Leukemia ALL, Chronic Lymphocytic Leukemia CLL, Acute Myeloid Leukemia AML …
-
Trained immunity: A new player in cancer immunotherapy
18 Jun 2025 21:40 GMT
… in patients with high-risk chronic lymphocytic leukemia (Zent et al., 2015). β-Glucan … I/II
High-risk chronic lymphocytic leukemia
Soluble/I.V.
Alemtuzumab …